MKI67 and prostate carcinoma: As shown in Fig. 4C, tumors overexpressing CAM2KN1 have reduced expression of Bcl-2, Ki67 and increased p21 and Bax expression, suggesting that gain of CAM2KN1 promotes apoptosis in prostate cancer cells.